Impact of non-pharmaceutical interventions on circulating respiratory viruses during the COVID-19 pandemic in Turkey

Non-pharmaceutical interventions (NPIs) applied to limit the SARS-CoV-2 pandemic also affect the circulation and seasonal characteristics of other respiratory viruses. Assess the impact of NPIs on the spread and seasonal characteristics of non-SARS-CoV-2 respiratory viruses and examine viral respira...

Full description

Saved in:
Bibliographic Details
Published in:Annals of Saudi medicine 2023-05, Vol.43 (3), p.143-153
Main Authors: Kırca, Füsun, Aydoğan, Sibel, Gozalan, Aysegul, Güler, Ezgi, Uyan Erten, Ayşegül Zehra, Özşen Uygur, Ayşe Sena, Doğan, Alper, Dinc, Bedia
Format: Article
Language:English
Subjects:
COVID-19 - epidemiology
COVID-19 - prevention & control
Humans
Original
Pandemics - prevention & control
Respiratory Tract Infections - epidemiology
Respiratory Tract Infections - prevention & control
Retrospective Studies
SARS-CoV-2
Turkey - epidemiology
Virus Diseases - epidemiology
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-pharmaceutical interventions (NPIs) applied to limit the SARS-CoV-2 pandemic also affect the circulation and seasonal characteristics of other respiratory viruses. Assess the impact of NPIs on the spread and seasonal characteristics of non-SARS-CoV-2 respiratory viruses and examine viral respiratory co-infections. Retrospective cohort SETTING: Single center in Turkey. Syndromic multiplex viral polymerase chain reaction (mPCR) panel results of patients admitted to the Ankara Bilkent City Hospital with symptoms of acute respiratory tract infection between April 1, 2020 and October 30, 2022 were evaluated. Two study periods before and after 1 July 2021, when the restrictions were discontinued, were statistically analyzed and compared to determine the effect of NPIs on circulating respiratory viruses. Prevalence of respiratory viruses as determined by syndromic mPCR panel. 11300 patient samples were evaluated. At least one respiratory tract virus was detected in 6250 (55.3%) patients. Of these, at least one respiratory virus was detected in 5% in the first period (between April 1, 2020 and June 30, 2021, when NPIs were applied), and in 95% in the second period (between July 1, 2021 and October 30, 2022, when NPIs were relaxed). After the removal of NPIs, there was a statistically significant increase in hRV/EV, RSV-A/B, Flu A/H3, hBoV, hMPV, PIV-1, PIV-4, hCoV-OC43, PIV-2 and hCoV-NL63 (
ISSN:0256-4947
0975-4466
DOI:10.5144/0256-4947.2023.143